GlassScriptPhysician profile
Ronak S Patel
NPI 1598150880
$6,577.49
in general payments reported to CMS, 2019-2025
25 companies · $1,564 in 2025
The $1,564 reported for 2025 was more than what a typical Glaucoma Specialist provider received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $964 · 2020: $1,163 · 2023: $1,323 · 2024: $1,563 · 2025: $1,564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,349.02 | 2019-2025 | Istent Trabecular Micro-Bypass System Model Is3, Ce-Marked Kxla System, Kxl System (Not Refurbished) |
| Alcon Vision LLC | $900.52 | 2023-2025 | Clareon, Rocklatan, Rhopressa |
| Bausch & Lomb Americas INC. | $600.83 | 2023-2025 | Vyzulta, Miebo, Xiidra |
| Johnson & Johnson Surgical Vision, INC. | $504.87 | 2023-2025 | Tecnis Iol, Tecnis Iol, Tecnis Simplicity |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $448.41 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $310.65 | 2023-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $280.59 | 2019 | |
| Abbvie INC. | $279.19 | 2023-2025 | |
| Harrow Eye, LLC | $274.17 | 2024-2025 | Vevye |
| Ivantis, INC | $245.05 | 2019-2020 | |
| New World Medical,INC. | $211.25 | 2020-2025 | Kahook Dual Blade, Streamline, Ahmed Glaucoma Valve |
| Oyster Point Pharma, INC. | $208.90 | 2023-2025 | Tyrvaya, Ryzumvi |
| Optos, INC. | $150.05 | 2020 | |
| Amgen INC. | $140.31 | 2024-2025 | Tepezza |
| Iridex Corporation | $119.77 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $119.02 | 2023 | Syfovre |
| Rxsight INC | $111.07 | 2024-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Tarsus Pharmaceuticals, INC. | $76.71 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $75.96 | 2024-2025 | Oxervate |
| Sight Sciences, INC. | $44.77 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Scilex Pharmaceuticals INC. | $37.90 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $32.19 | 2025 | Purified Cortrophin Gel |
| Biotissue Holdings INC. | $22.17 | 2025 | |
| Carl Zeiss Meditec USA, INC. | $17.80 | 2024 | Humphrey Hfa |
| E.R. Squibb & Sons, L.L.C. | $16.32 | 2025 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronak Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.